New ontologies for process data will help biopharmaceutical manufacturers enhance the interoperability of drug production operations ...

Merck KGaA has reached an agreement with SpringWorks on a $47-per-share takeover deal that values the US biotech at $3.9 billion. The acquisition – which was confirmed to be in the final stages of ...

Merck & Co's earlier efforts to find new therapies for Alzheimer's disease resulted in failure, but the company is returning to the field via an R&D alliance with UK biotech Cerevance that will seek ...

Get the annual and quarterly balance sheet of Merck & Co., Inc. (MRK) including details of assets, liabilities and shareholders' equity.

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care ...

Find the latest Merck & Company, Inc. MRK analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports.